Microarray Market By Product & Services (Consumable, Instruments, Software and Services), By Type (DNA Microarray, Protein Microarray, Other Microarray), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Other End Users): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global microarray market was valued at $3,947.18 million in 2021, and is projected to reach $8,399.97 million by 2031, registering a CAGR of 7.8% from 2022 to 2031.
The microarray is a laboratory tool used to detect the expression of thousands of genes at the same time. DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. DNA microarrays are used in clinical diagnostic tests for some diseases. Sometimes they are also used to determine which drugs might be best prescribed for particular individuals, because genes determine how our bodies handle the chemistry related to those drugs. With the advent of new DNA sequencing technologies, some of the tests for which microarrays were used in the past now use DNA sequencing instead. But microarray tests still tend to be less expensive than sequencing, so they may be used for very large studies, as well as for some clinical tests. The principle behind microarrays is that the unknown DNA molecules are cut into fragments by restriction endonucleases; fluorescent markers are attached to these DNA fragments. These are then allowed to react with probes of the DNA chip. Then the target DNA fragments along with complementary sequences bind to the DNA probes. The remaining DNA fragments are washed away. The target DNA pieces can be identified by their fluorescence emission by passing a laser beam. A computer is used to record the pattern of fluorescence emission and DNA identification. This technique of employing DNA chips is very rapid, besides being sensitive and specific for the identification of several DNA fragments simultaneously.
The global microarray market is anticipated to show significant market growth during the forecast period, owing to increase in number of on-going R&D activities, increase in government support for research and development activities and increase in healthcare expenditure. Furthermore, rise in the incidence of cancer, the rapidly evolving information and software technology and emerging bioinformatics are considerably contributing toward the market growth. However, limitations of microarray analysis technology and lack of skilled professionals are negatively impacting the market growth. Conversely, the surge in applications of microarray technique in medical field offers the lucrative opportunities for the growth of the market.
The global microarray market is segmented on the basis of product & services, type, end user and region. Based on product & services, the market is classified into consumable, instruments, software and services. Furthermore, the consumable segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. Also, the instruments segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. The software and services segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. By type, the market is classified into DNA microarray, protein microarray, and other microarray. By end user, the market is classified into research and academic institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, other end users. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
The major companies profiled in the report include Agilent Technologies, Inc., Arrayit Corporation, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation (Molecular Devices), Diasorin Group (Luminex Corporation), GE company (GE Healthcare), Illumina, Inc., Invitae Corporation, Merck KGaA, Microarray Inc., NextGen Sciences, PathogenDx, Inc., PerkinElmer Inc., RayBiotech Life, Inc., Schott Minifab (Applied Microarrays), Thermo Fisher Scientific, Inc (Affymetrix, Inc.).
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microarray market analysis from 2021 to 2031 to identify the prevailing microarray market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the microarray market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global microarray market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Services
Consumable
Application
Research Applications
Drug Discovery
Disease Diagnostics
Other Applications
Instruments
Application
Research Applications
Drug Discovery
Disease Diagnostics
Other Applications
Software and Services
Application
Research Applications
Drug Discovery
Disease Diagnostics
Other Applications
By Type
DNA Microarray
Protein Microarray
Other Microarray
By End User
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Other End Users
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest Of Asia-Pacific
LAMEA
Saudi Arabia
South Arabia
Rest Of LAMEA
Brazil
Key Market Players
Agilent Technologies, Inc.
Arrayit Corporation
bioMérieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
Diasorin Group
GE Healthcare
Illumina, Inc.
Invitae Corporation
Merck KGaA
Microarray Inc.
NextGen Sciences
PathogenDx, Inc.
PerkinElmer Inc.
RayBiotech Life, Inc.
Schott Minifab
Thermo Fisher Scientific, Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: MICROARRAY MARKET, BY PRODUCT & SERVICES
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Consumable
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Consumable Microarray Market by Application
- 4.2.4.1 Research Applications Market size and forecast, by region
- 4.2.4.2 Drug Discovery Market size and forecast, by region
- 4.2.4.3 Disease Diagnostics Market size and forecast, by region
- 4.2.4.4 Other Applications Market size and forecast, by region
- 4.3 Instruments
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Instruments Microarray Market by Application
- 4.3.4.1 Research Applications Market size and forecast, by region
- 4.3.4.2 Drug Discovery Market size and forecast, by region
- 4.3.4.3 Disease Diagnostics Market size and forecast, by region
- 4.3.4.4 Other Applications Market size and forecast, by region
- 4.4 Software and Services
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.4.4 Software and Services Microarray Market by Application
- 4.4.4.1 Research Applications Market size and forecast, by region
- 4.4.4.2 Drug Discovery Market size and forecast, by region
- 4.4.4.3 Disease Diagnostics Market size and forecast, by region
- 4.4.4.4 Other Applications Market size and forecast, by region
- CHAPTER 5: MICROARRAY MARKET, BY BY TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 DNA Microarray
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Protein Microarray
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Other Microarray
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: MICROARRAY MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Research and Academic Institutes
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Pharmaceutical and Biotechnology Companies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Diagnostic Laboratories
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Other End Users
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: MICROARRAY MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product & Services
- 7.2.2.1 North America Consumable Microarray Market by Application
- 7.2.2.2 North America Instruments Microarray Market by Application
- 7.2.2.3 North America Software and Services Microarray Market by Application
- 7.2.3 North America Market size and forecast, by By Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product & Services
- 7.2.5.1.2 Market size and forecast, by By Type
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product & Services
- 7.2.5.2.2 Market size and forecast, by By Type
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product & Services
- 7.2.5.3.2 Market size and forecast, by By Type
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product & Services
- 7.3.2.1 Europe Consumable Microarray Market by Application
- 7.3.2.2 Europe Instruments Microarray Market by Application
- 7.3.2.3 Europe Software and Services Microarray Market by Application
- 7.3.3 Europe Market size and forecast, by By Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product & Services
- 7.3.5.1.2 Market size and forecast, by By Type
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product & Services
- 7.3.5.2.2 Market size and forecast, by By Type
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product & Services
- 7.3.5.3.2 Market size and forecast, by By Type
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product & Services
- 7.3.5.4.2 Market size and forecast, by By Type
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product & Services
- 7.3.5.5.2 Market size and forecast, by By Type
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product & Services
- 7.3.5.6.2 Market size and forecast, by By Type
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product & Services
- 7.4.2.1 Asia-Pacific Consumable Microarray Market by Application
- 7.4.2.2 Asia-Pacific Instruments Microarray Market by Application
- 7.4.2.3 Asia-Pacific Software and Services Microarray Market by Application
- 7.4.3 Asia-Pacific Market size and forecast, by By Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product & Services
- 7.4.5.1.2 Market size and forecast, by By Type
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product & Services
- 7.4.5.2.2 Market size and forecast, by By Type
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product & Services
- 7.4.5.3.2 Market size and forecast, by By Type
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product & Services
- 7.4.5.4.2 Market size and forecast, by By Type
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product & Services
- 7.4.5.5.2 Market size and forecast, by By Type
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product & Services
- 7.4.5.6.2 Market size and forecast, by By Type
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product & Services
- 7.5.2.1 LAMEA Consumable Microarray Market by Application
- 7.5.2.2 LAMEA Instruments Microarray Market by Application
- 7.5.2.3 LAMEA Software and Services Microarray Market by Application
- 7.5.3 LAMEA Market size and forecast, by By Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product & Services
- 7.5.5.1.2 Market size and forecast, by By Type
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product & Services
- 7.5.5.2.2 Market size and forecast, by By Type
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Arabia
- 7.5.5.3.1 Market size and forecast, by Product & Services
- 7.5.5.3.2 Market size and forecast, by By Type
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product & Services
- 7.5.5.4.2 Market size and forecast, by By Type
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Agilent Technologies, Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Arrayit Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 bioMérieux SA
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Bio-Rad Laboratories Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Danaher Corporation
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Diasorin Group
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 GE Healthcare
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Illumina, Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Invitae Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Merck KGaA
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Microarray Inc.
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 NextGen Sciences
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 PathogenDx, Inc.
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 PerkinElmer Inc.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 RayBiotech Life, Inc.
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Schott Minifab
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Thermo Fisher Scientific, Inc
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 2. MICROARRAY MARKET, FOR CONSUMABLE, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. MICROARRAY MARKET FOR CONSUMABLE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL CONSUMABLE MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 5. MICROARRAY MARKET, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. MICROARRAY MARKET, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. MICROARRAY MARKET, FOR DISEASE DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. MICROARRAY MARKET, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. MICROARRAY MARKET, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. MICROARRAY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. GLOBAL INSTRUMENTS MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 12. MICROARRAY MARKET, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. MICROARRAY MARKET, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. MICROARRAY MARKET, FOR DISEASE DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. MICROARRAY MARKET, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. MICROARRAY MARKET, FOR SOFTWARE AND SERVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. MICROARRAY MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. GLOBAL SOFTWARE AND SERVICES MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 19. MICROARRAY MARKET, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. MICROARRAY MARKET, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. MICROARRAY MARKET, FOR DISEASE DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. MICROARRAY MARKET, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 23. GLOBAL MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 24. MICROARRAY MARKET, FOR DNA MICROARRAY, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. MICROARRAY MARKET FOR DNA MICROARRAY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. MICROARRAY MARKET, FOR PROTEIN MICROARRAY, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. MICROARRAY MARKET FOR PROTEIN MICROARRAY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. MICROARRAY MARKET, FOR OTHER MICROARRAY, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. MICROARRAY MARKET FOR OTHER MICROARRAY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. GLOBAL MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 31. MICROARRAY MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 32. MICROARRAY MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 33. MICROARRAY MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 34. MICROARRAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. MICROARRAY MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 36. MICROARRAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. MICROARRAY MARKET, FOR OTHER END USERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 38. MICROARRAY MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 39. MICROARRAY MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 40. NORTH AMERICA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 41. NORTH AMERICA CONSUMABLE MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 42. NORTH AMERICA INSTRUMENTS MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 43. NORTH AMERICA SOFTWARE AND SERVICES MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. NORTH AMERICA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 45. NORTH AMERICA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 46. NORTH AMERICA MICROARRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 47. U.S. MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 48. U.S. MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 49. U.S. MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. CANADA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 51. CANADA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 52. CANADA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. MEXICO MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 54. MEXICO MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 55. MEXICO MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 56. EUROPE MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 57. EUROPE CONSUMABLE MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 58. EUROPE INSTRUMENTS MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 59. EUROPE SOFTWARE AND SERVICES MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 60. EUROPE MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 61. EUROPE MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. EUROPE MICROARRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 63. GERMANY MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 64. GERMANY MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 65. GERMANY MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 66. FRANCE MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 67. FRANCE MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 68. FRANCE MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. UK MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 70. UK MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 71. UK MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. ITALY MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 73. ITALY MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 74. ITALY MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 75. SPAIN MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 76. SPAIN MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 77. SPAIN MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 78. REST OF EUROPE MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 79. REST OF EUROPE MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 80. REST OF EUROPE MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. ASIA-PACIFIC MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 82. ASIA-PACIFIC CONSUMABLE MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 83. ASIA-PACIFIC INSTRUMENTS MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. ASIA-PACIFIC SOFTWARE AND SERVICES MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 85. ASIA-PACIFIC MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 86. ASIA-PACIFIC MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. ASIA-PACIFIC MICROARRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 88. CHINA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 89. CHINA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 90. CHINA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 91. JAPAN MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 92. JAPAN MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 93. JAPAN MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 94. INDIA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 95. INDIA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 96. INDIA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. AUSTRALIA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 98. AUSTRALIA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 99. AUSTRALIA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 100. SOUTH KOREA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 101. SOUTH KOREA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 102. SOUTH KOREA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 103. REST OF ASIA-PACIFIC MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 104. REST OF ASIA-PACIFIC MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 105. REST OF ASIA-PACIFIC MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 106. LAMEA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 107. LAMEA CONSUMABLE MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 108. LAMEA INSTRUMENTS MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 109. LAMEA SOFTWARE AND SERVICES MICROARRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 110. LAMEA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 111. LAMEA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 112. LAMEA MICROARRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 113. BRAZIL MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 114. BRAZIL MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 115. BRAZIL MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 116. SAUDI ARABIA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 117. SAUDI ARABIA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 118. SAUDI ARABIA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 119. SOUTH ARABIA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 120. SOUTH ARABIA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 121. SOUTH ARABIA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 122. REST OF LAMEA MICROARRAY MARKET, BY PRODUCT & SERVICES, 2021-2031 ($MILLION)
- TABLE 123. REST OF LAMEA MICROARRAY MARKET, BY BY TYPE, 2021-2031 ($MILLION)
- TABLE 124. REST OF LAMEA MICROARRAY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 125.AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 126.AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
- TABLE 127.AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 128.AGILENT TECHNOLOGIES, INC.: NET SALES,
- TABLE 129.AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
- TABLE 130.ARRAYIT CORPORATION: COMPANY SNAPSHOT
- TABLE 131.ARRAYIT CORPORATION: OPERATING SEGMENTS
- TABLE 132.ARRAYIT CORPORATION: PRODUCT PORTFOLIO
- TABLE 133.ARRAYIT CORPORATION: NET SALES,
- TABLE 134.ARRAYIT CORPORATION: KEY STRATERGIES
- TABLE 135.BIOMÉRIEUX SA: COMPANY SNAPSHOT
- TABLE 136.BIOMÉRIEUX SA: OPERATING SEGMENTS
- TABLE 137.BIOMÉRIEUX SA: PRODUCT PORTFOLIO
- TABLE 138.BIOMÉRIEUX SA: NET SALES,
- TABLE 139.BIOMÉRIEUX SA: KEY STRATERGIES
- TABLE 140.BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
- TABLE 141.BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
- TABLE 142.BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
- TABLE 143.BIO-RAD LABORATORIES INC.: NET SALES,
- TABLE 144.BIO-RAD LABORATORIES INC.: KEY STRATERGIES
- TABLE 145.DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 146.DANAHER CORPORATION: OPERATING SEGMENTS
- TABLE 147.DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 148.DANAHER CORPORATION: NET SALES,
- TABLE 149.DANAHER CORPORATION: KEY STRATERGIES
- TABLE 150.DIASORIN GROUP: COMPANY SNAPSHOT
- TABLE 151.DIASORIN GROUP: OPERATING SEGMENTS
- TABLE 152.DIASORIN GROUP: PRODUCT PORTFOLIO
- TABLE 153.DIASORIN GROUP: NET SALES,
- TABLE 154.DIASORIN GROUP: KEY STRATERGIES
- TABLE 155.GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 156.GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 157.GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 158.GE HEALTHCARE: NET SALES,
- TABLE 159.GE HEALTHCARE: KEY STRATERGIES
- TABLE 160.ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 161.ILLUMINA, INC.: OPERATING SEGMENTS
- TABLE 162.ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 163.ILLUMINA, INC.: NET SALES,
- TABLE 164.ILLUMINA, INC.: KEY STRATERGIES
- TABLE 165.INVITAE CORPORATION: COMPANY SNAPSHOT
- TABLE 166.INVITAE CORPORATION: OPERATING SEGMENTS
- TABLE 167.INVITAE CORPORATION: PRODUCT PORTFOLIO
- TABLE 168.INVITAE CORPORATION: NET SALES,
- TABLE 169.INVITAE CORPORATION: KEY STRATERGIES
- TABLE 170.MERCK KGAA: COMPANY SNAPSHOT
- TABLE 171.MERCK KGAA: OPERATING SEGMENTS
- TABLE 172.MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 173.MERCK KGAA: NET SALES,
- TABLE 174.MERCK KGAA: KEY STRATERGIES
- TABLE 175.MICROARRAY INC.: COMPANY SNAPSHOT
- TABLE 176.MICROARRAY INC.: OPERATING SEGMENTS
- TABLE 177.MICROARRAY INC.: PRODUCT PORTFOLIO
- TABLE 178.MICROARRAY INC.: NET SALES,
- TABLE 179.MICROARRAY INC.: KEY STRATERGIES
- TABLE 180.NEXTGEN SCIENCES: COMPANY SNAPSHOT
- TABLE 181.NEXTGEN SCIENCES: OPERATING SEGMENTS
- TABLE 182.NEXTGEN SCIENCES: PRODUCT PORTFOLIO
- TABLE 183.NEXTGEN SCIENCES: NET SALES,
- TABLE 184.NEXTGEN SCIENCES: KEY STRATERGIES
- TABLE 185.PATHOGENDX, INC.: COMPANY SNAPSHOT
- TABLE 186.PATHOGENDX, INC.: OPERATING SEGMENTS
- TABLE 187.PATHOGENDX, INC.: PRODUCT PORTFOLIO
- TABLE 188.PATHOGENDX, INC.: NET SALES,
- TABLE 189.PATHOGENDX, INC.: KEY STRATERGIES
- TABLE 190.PERKINELMER INC.: COMPANY SNAPSHOT
- TABLE 191.PERKINELMER INC.: OPERATING SEGMENTS
- TABLE 192.PERKINELMER INC.: PRODUCT PORTFOLIO
- TABLE 193.PERKINELMER INC.: NET SALES,
- TABLE 194.PERKINELMER INC.: KEY STRATERGIES
- TABLE 195.RAYBIOTECH LIFE, INC.: COMPANY SNAPSHOT
- TABLE 196.RAYBIOTECH LIFE, INC.: OPERATING SEGMENTS
- TABLE 197.RAYBIOTECH LIFE, INC.: PRODUCT PORTFOLIO
- TABLE 198.RAYBIOTECH LIFE, INC.: NET SALES,
- TABLE 199.RAYBIOTECH LIFE, INC.: KEY STRATERGIES
- TABLE 200.SCHOTT MINIFAB: COMPANY SNAPSHOT
- TABLE 201.SCHOTT MINIFAB: OPERATING SEGMENTS
- TABLE 202.SCHOTT MINIFAB: PRODUCT PORTFOLIO
- TABLE 203.SCHOTT MINIFAB: NET SALES,
- TABLE 204.SCHOTT MINIFAB: KEY STRATERGIES
- TABLE 205.THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
- TABLE 206.THERMO FISHER SCIENTIFIC, INC: OPERATING SEGMENTS
- TABLE 207.THERMO FISHER SCIENTIFIC, INC: PRODUCT PORTFOLIO
- TABLE 208.THERMO FISHER SCIENTIFIC, INC: NET SALES,
- TABLE 209.THERMO FISHER SCIENTIFIC, INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.MICROARRAY MARKET SEGMENTATION
- FIGURE 2.MICROARRAY MARKET,2021-2031
- FIGURE 3.MICROARRAY MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.MICROARRAY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.MICROARRAY MARKET,BY PRODUCT & SERVICES,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONSUMABLE MICROARRAY MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS MICROARRAY MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SOFTWARE AND SERVICES MICROARRAY MARKET,2021-2031(%)
- FIGURE 16.MICROARRAY MARKET,BY BY TYPE,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DNA MICROARRAY MICROARRAY MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PROTEIN MICROARRAY MICROARRAY MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHER MICROARRAY MICROARRAY MARKET,2021-2031(%)
- FIGURE 20.MICROARRAY MARKET,BY END USER,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF RESEARCH AND ACADEMIC INSTITUTES MICROARRAY MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MICROARRAY MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES MICROARRAY MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHER END USERS MICROARRAY MARKET,2021-2031(%)
- FIGURE 25.MICROARRAY MARKET BY REGION,2021
- FIGURE 26.U.S. MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 31.UK MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 35.CHINA MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN MICROARRAY MARKET,2021-2031($MILLION)
- FIGURE 37.INDIA MICROARR
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook